Identification and validation of parthanatos-related genes in end-stage renal disease
Background End-Stage Renal Disease (ESRD) is a severe chronic kidney disease with a rising global incidence, often accompanied by various complications, severely impacting patients’ quality of life. Parthanatos plays a crucial role in the pathogenesis of multiple diseases. This study aims to explore...
Saved in:
| Main Authors: | Xuan Dai, Lianfang Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2519834 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance
by: Junjie Tang, et al.
Published: (2025-05-01) -
Identification of parthanatos-related molecular subtypes and development of prognostic risk models in ovarian cancer based on multi-omics analysis
by: Xiaoying Qi, et al.
Published: (2025-07-01) -
PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos
by: Huiming Nong, et al.
Published: (2025-06-01) -
The value and safety analysis of renal biopsy in patients with suspicious diagnosis of end-stage renal disease
by: YIN Na, et al.
Published: (2018-01-01) -
Utilization of hospice and nonhospice care in patients with end-stage renal disease on dialysis
by: Shu-Chen Wang, et al.
Published: (2022-01-01)